Light-activated nanoparticles for #neovascular eye disease. Learn more about the innovations from Boston Children's Kohane lab: ms.spr.ly/6014TDreQ #drugdelivery #eyedisease

Check out this exciting new @NanoLetters paper from Kohane’s lab @BostonChildrens @harvardmed. Targeting Nanoparticles to Bioengineered Human Vascular Networks! pubs.acs.org/doi/10.1021/acs…

Top pick of 2019 #4: Beyond #multidrugresistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium #tuberculosis resistance prediction Read the full #openaccess paper from Dr Kohane lab here -> thelancet.com/journals/ebiom…

I'm so grateful for the opportunity to do research in the Kohane lab at BCH this summer, and I'm honored to present my work today at #ANES18 meeting. Thank you #FAER for the generous funding and investment in my medical education.

This week's #StaffSpotlight is Dr. Daniel Kohane, Vice Chair of Research for @bch_anesthesia. Swipe to learn more about Dr. Kohane and his interests. #WeAre BostonChildrens

[Viewpoint] 'Keeping Nanomedicine on Target' "A principal purpose of targeting or triggering is to improve the active agents’ therapeutic indices by preferentially increasing their concentrations at the desired site of effect." Read it here --> acspubs.co/JMHI50DfPtn

"Sometimes you can achieve really big things by thinking really, really small." - nanotechnologist, Daniel Kohane #TEDMED

Daniel Kohane to speak at #CRSBoston: Treatment of otitis media by #transtympanic delivery of antibiotics ow.ly/UKSW304sPQI